About PhaseFolio

The public record of drug development, connected.

A drug reaches patients through a long public record: trial registrations, regulatory decisions, company filings, publications. PhaseFolio connects that record so that anyone reading a comparison or a case can trace each value to its source.

The work

Read the record. Keep the link.

The facts behind a diligence question are public but scattered: a registry entry here, an approval there, a filing somewhere else, each in its own format and on its own schedule. PhaseFolio retrieves those records, keeps each value as the source recorded it, and marks what was not found or not searched instead of filling the gap.

Atlas compares trial records field by field. Workspace keeps the evidence, assumptions and scenarios of an asset case in one record. Sentinel is in development. None of them is clinical decision support: there is no treatment advice, no efficacy ranking and no verdict, only cited facts and the judgment of the people reading them.

Governance

The method stays open to inspection.

Sources and their status

The Sources page lists every source, which are live in Atlas and which are planned, and when that list was last reviewed.

Security and data handling

The security page describes tenancy, access, retention and the vendors that process data.

People

Who builds it.

TA

Tamal Adebisi

Founder and methodology author

MS Finance candidate at Johns Hopkins University and author of the PhaseFolio rNPV methodology, multi-indication backtest framework, model architecture, and clinical data pipeline.

LinkedIn
JB

Jeromie Ballreich, PhD

Scientific and strategic advisor

Associate Research Professor in the Department of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health, advising PhaseFolio on valuation methodology and benchmarking.

Get started

Create an account and start with one comparison.

Sign up